Skip to content

DOKTER THOMAS DEGRYSE

Active
Private limited companyfounded 2012active for 14 yearsBlijde-Inkomststraat 146, 3000 Leuven, BelgiumKBO/BCE: BE 0846.904.921
Summary

DOKTER THOMAS DEGRYSE has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €387,784 and a net result of €127,907. Equity has been stable since 2018 (±1% per year). Its solvency ranks better than 74% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-06-2012 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment units
2.213.010.656 3000 Leuven, since 27-06-2012
2.360.035.041 3290 Diest, since 29-05-2024
Financial year end
31 December
Peppol
Reachable since 28-07-2024

Board and ownership

Last known board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€209,215
▲ 34.7%
Turnover
≈ €390,000
estimated
Profit
€127,907
▲ 45.8%
Equity
€387,784
▲ 45.1%
Total assets
€468,882
▲ 0.7%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 17.97, cash €98,304Equity €387,784 (82.7% of total assets)Figures for financial year 2025 (filed on 20-04-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 75% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+18
equity 82.7% of total assets
Liquidity 76+19
short-term debt 3.5% · cash 21.0%
Profitability 100+8
return on assets 27.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026highest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 17.97 (2.11 in 2024), above the usual 1.5. Short-term debt is 3.5% and cash 21% of total assets. 17.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 58% on liquidity, 80% on profitability and 78% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 17.97, cash €98,304
NBB · annual accounts
lowers risk · Equity €387,784 (82.7% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 20-04-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €387,784
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-04-2026, 107 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
107 days early
2024
146 days early
2023
44 days early
2022
26 days early
2021
13 days early
2020
19 days early
2019
11 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 52 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 June (4 of the last 5 accounts filed within 64 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €127,907 8 years View
  • Positive: Equity rose in 2025from €267,277 to €387,784 ▲ 45.1% View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Recent changes

  1. · Gazette deed Resignation: DEGRYSE Thomas (director)Appointment: DEGRYSE Thomas (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as DOKTER THOMAS DEGRYSE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €440,000 and €464,000, founded between 2010 and 2013.

CompanyTotal assetsGross margin
DOKTER THOMAS DEGRYSE Leuven€468,882€209,215
Dr. S. Verstraeten Leuven€463,777€219,797
DR. VROMAN PHILIPPE, MEDISCHE ONCOLOGIE Asse€453,570€212,528
Dokter Hisco ROBIJN Orthopedie Tienen€455,799€208,300
DR. YANKO Elisabeth Drogenbos€440,124€222,142
CHERON ANNE-CELINE Charleroi€454,889€216,263
Dr. Wim Huybrechts Edegem€450,946€197,571
Full comparison

Key facts about DOKTER THOMAS DEGRYSE

What is the company number of DOKTER THOMAS DEGRYSE?
The company number of DOKTER THOMAS DEGRYSE is 0846.904.921. The VAT number is the same number with BE in front: BE 0846.904.921.
Where is DOKTER THOMAS DEGRYSE based?
The registered office is at Blijde-Inkomststraat 146, 3000 Leuven.Company details
What does DOKTER THOMAS DEGRYSE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER THOMAS DEGRYSE?
The legal form of DOKTER THOMAS DEGRYSE is Private limited company (BV).
When was DOKTER THOMAS DEGRYSE founded?
DOKTER THOMAS DEGRYSE was founded on 27-06-2012.
Is DOKTER THOMAS DEGRYSE still active?
Yes, DOKTER THOMAS DEGRYSE is an active enterprise in the KBO register.
What is the turnover of DOKTER THOMAS DEGRYSE?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €209,215 and 42 comparable companies (NACE 86220). It probably lies between €330,000 and €510,000.Financials
Is DOKTER THOMAS DEGRYSE profitable?
In financial year 2025, DOKTER THOMAS DEGRYSE made a profit of €127,907.
Where can I find the annual accounts of DOKTER THOMAS DEGRYSE?
DOKTER THOMAS DEGRYSE filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER THOMAS DEGRYSE due?
DOKTER THOMAS DEGRYSE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.